POTUS gets a Warning Letter

If a pharmaceutical company actively promotes one of its products for conditions other than those approved by the Food and Drug Administration, it ’s considered “violative behavior” and often results in what’s known in the regulatory world as a “warning letter” -- official correspondence from the FDA ordering the firm to cease and desist from such communications. But can the FDA send a warning letter to the President of the United States?
Source: drugwonks.com Blog - Category: Pharmaceuticals Source Type: blogs